Employers and Biosimilars: Stories from the Real World

Event Image

Employers and Biosimilars: Stories from the Real World

Dial-in Instructions:
Webinar link is in the registration confirmation email.
When:  Feb 16, 2023 from 01:00 PM to 02:30 PM (CT)

Event Description

As the pipeline for biologic drugs continues to flow, employers are looking to biosimilars for help in controlling the ever-increasing financial burden on employee benefits. Biosimilars are considered “highly similar” to FDA-approved biologic originator drugs, with no clinically meaningful differences in terms of safety, purity and potency. Currently, over 80% of biosimilars run through the medical claims side. Employers need to require that clinical protocols are clearly defined in carrier contracts and mandate the appropriate use of biosimilars for patient efficacy and cost effective outcomes. Biosimilars can reduce pharmacy benefit costs significantly, just as generic drugs have done.

At this webinar, you will:

  • Understand the employer steps required to implement biosimilars
  • Identify best practices for optimal plan savings
  • Learn how to address the challenges in promoting individual access and adoption
  • Hear how artificial price increases, rebates and other barriers are used to discourage coverage and what to do about it
  • Walk away with employer action steps to support your strategy


  • Jung Alex Jung Founder Alex Jung Consulting LLC
  • Dwyer Kim Dwyer Vice President Inspera Health; MBGH Board Ex-Officio

Registration Fees

  • Members $0
  • Employer Non-Members $15
  • Non-Members $50